Enriqueta274 Barrows492
=======================
Race:                Black
Ethnicity:           Non-Hispanic
Gender:              F
Age:                 DECEASED
Birth Date:          1965-06-16
Marital Status:      M
--------------------------------------------------------------------------------
ALLERGIES:
No Known Allergies
--------------------------------------------------------------------------------
ENCOUNTER
2019-03-29 : Encounter at HEBREW REHABILITATION CENTER : Encounter for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
Type: inpatient
   
   MEDICATIONS:
  2019-04-07 : Etoposide 100 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-04-07 : Cisplatin 50 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-04-06 : Etoposide 100 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-04-06 : Cisplatin 50 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-04-05 : Etoposide 100 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-04-05 : Cisplatin 50 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-04-03 : Etoposide 100 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-04-03 : Cisplatin 50 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-04-02 : Etoposide 100 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-04-02 : Cisplatin 50 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-04-01 : Etoposide 100 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-04-01 : Cisplatin 50 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-03-31 : Etoposide 100 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-03-31 : Cisplatin 50 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-03-30 : Etoposide 100 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-03-30 : Cisplatin 50 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-03-29 : Etoposide 100 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-03-29 : Cisplatin 50 MG Injection for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
   
   CONDITIONS:
   
   CARE PLANS:
   
   REPORTS:
  2019-03-29 : Comprehensive metabolic 2000 panel - Serum or Plasma
           - Glucose [Mass/volume] in Blood           84.9 mg/dL
           - Urea nitrogen [Mass/volume] in Blood     18.1 mg/dL
           - Creatinine [Mass/volume] in Blood        3.1 mg/dL
           - Calcium [Mass/volume] in Blood           8.9 mg/dL
           - Sodium [Moles/volume] in Blood           137.6 mmol/L
           - Potassium [Moles/volume] in Blood        4.3 mmol/L
           - Chloride [Moles/volume] in Blood         108.7 mmol/L
           - Carbon dioxide, total [Moles/volume] in Blood 27.0 mmol/L
           - Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 9.8 mL/min
           - Protein [Mass/volume] in Serum or Plasma 6.3 g/dL
           - Albumin [Mass/volume] in Serum or Plasma 4.5 g/dL
           - Globulin [Mass/volume] in Serum by calculation 2.3 g/L
           - Bilirubin.total [Mass/volume] in Serum or Plasma 0.1 mg/dL
           - Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 119.8 U/L
           - Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 35.4 U/L
           - Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 35.4 U/L
  2019-03-29 : Urinalysis macro (dipstick) panel - Urine
           - Appearance of Urine                      Cloudy urine (finding) {nominal}
           - Odor of Urine                            Urine smell ammoniacal (finding) {nominal}
           - Clarity of Urine                         Translucent (qualifier value) {nominal}
           - Color of Urine                           Brown color (qualifier value) {nominal}
           - Glucose [Mass/volume] in Urine by Test strip 0.6 mg/dL
           - Glucose [Presence] in Urine by Test strip Urine glucose test = ++ (finding) {nominal}
           - Bilirubin.total [Mass/volume] in Urine by Test strip 1.4 mg/dL
           - Bilirubin.total [Presence] in Urine by Test strip Finding of bilirubin in urine (finding) {nominal}
           - Ketones [Mass/volume] in Urine by Test strip 18.0 mg/dL
           - Ketones [Presence] in Urine by Test strip Urine ketone test = +++ (finding) {nominal}
           - Specific gravity of Urine by Test strip  1.0 {nominal}
           - pH of Urine by Test strip                5.6 pH
           - Protein [Mass/volume] in Urine by Test strip 372.6 mg/dL
           - Protein [Presence] in Urine by Test strip Urine protein test = +++ (finding) {nominal}
           - Nitrite [Presence] in Urine by Test strip Urine nitrite negative (finding) {nominal}
           - Hemoglobin [Presence] in Urine by Test strip Urine blood test = negative (finding) {nominal}
           - Leukocyte esterase [Presence] in Urine by Test strip Urine leukocyte test negative (finding) {nominal}
  2019-03-29 : CBC panel - Blood by Automated count
           - Leukocytes [#/volume] in Blood by Automated count 2.3 10*3/uL
           - Erythrocytes [#/volume] in Blood by Automated count 4.1 10*6/uL
           - Hemoglobin [Mass/volume] in Blood        13.4 g/dL
           - Hematocrit [Volume Fraction] of Blood by Automated count 44.5 %
           - MCV [Entitic volume] by Automated count  91.7 fL
           - MCH [Entitic mass] by Automated count    30.5 pg
           - MCHC [Mass/volume] by Automated count    34.8 g/dL
           - Erythrocyte distribution width [Entitic volume] by Automated count 42.6 fL
           - Platelets [#/volume] in Blood by Automated count 441.9 10*3/uL
           - Platelet distribution width [Entitic volume] in Blood by Automated count 392.6 fL
           - Platelet mean volume [Entitic volume] in Blood by Automated count 9.9 fL
   
   OBSERVATIONS:
  2019-04-07 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 8.0 {score}
  2019-04-06 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 6.0 {score}
  2019-04-05 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 6.0 {score}
  2019-04-04 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 8.0 {score}
  2019-04-02 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 6.0 {score}
  2019-04-01 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 8.0 {score}
  2019-03-31 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 10.0 {score}
  2019-03-30 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 5.0 {score}
  2019-03-29 : Pain severity - 0-10 verbal numeric rating [Score] - Reported 9.0 {score}
  2019-03-29 : Platelet mean volume [Entitic volume] in Blood by Automated count 9.9 fL
  2019-03-29 : Platelet distribution width [Entitic volume] in Blood by Automated count 392.6 fL
  2019-03-29 : Platelets [#/volume] in Blood by Automated count 441.9 10*3/uL
  2019-03-29 : Erythrocyte distribution width [Entitic volume] by Automated count 42.6 fL
  2019-03-29 : MCHC [Mass/volume] by Automated count    34.8 g/dL
  2019-03-29 : MCH [Entitic mass] by Automated count    30.5 pg
  2019-03-29 : MCV [Entitic volume] by Automated count  91.7 fL
  2019-03-29 : Hematocrit [Volume Fraction] of Blood by Automated count 44.5 %
  2019-03-29 : Hemoglobin [Mass/volume] in Blood        13.4 g/dL
  2019-03-29 : Erythrocytes [#/volume] in Blood by Automated count 4.1 10*6/uL
  2019-03-29 : Leukocytes [#/volume] in Blood by Automated count 2.3 10*3/uL
  2019-03-29 : Leukocyte esterase [Presence] in Urine by Test strip Urine leukocyte test negative (finding) {nominal}
  2019-03-29 : Hemoglobin [Presence] in Urine by Test strip Urine blood test = negative (finding) {nominal}
  2019-03-29 : Nitrite [Presence] in Urine by Test strip Urine nitrite negative (finding) {nominal}
  2019-03-29 : Protein [Presence] in Urine by Test strip Urine protein test = +++ (finding) {nominal}
  2019-03-29 : Protein [Mass/volume] in Urine by Test strip 372.6 mg/dL
  2019-03-29 : pH of Urine by Test strip                5.6 pH
  2019-03-29 : Specific gravity of Urine by Test strip  1.0 {nominal}
  2019-03-29 : Ketones [Presence] in Urine by Test strip Urine ketone test = +++ (finding) {nominal}
  2019-03-29 : Ketones [Mass/volume] in Urine by Test strip 18.0 mg/dL
  2019-03-29 : Bilirubin.total [Presence] in Urine by Test strip Finding of bilirubin in urine (finding) {nominal}
  2019-03-29 : Bilirubin.total [Mass/volume] in Urine by Test strip 1.4 mg/dL
  2019-03-29 : Glucose [Presence] in Urine by Test strip Urine glucose test = ++ (finding) {nominal}
  2019-03-29 : Glucose [Mass/volume] in Urine by Test strip 0.6 mg/dL
  2019-03-29 : Color of Urine                           Brown color (qualifier value) {nominal}
  2019-03-29 : Clarity of Urine                         Translucent (qualifier value) {nominal}
  2019-03-29 : Odor of Urine                            Urine smell ammoniacal (finding) {nominal}
  2019-03-29 : Appearance of Urine                      Cloudy urine (finding) {nominal}
  2019-03-29 : Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 35.4 U/L
  2019-03-29 : Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 35.4 U/L
  2019-03-29 : Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 119.8 U/L
  2019-03-29 : Bilirubin.total [Mass/volume] in Serum or Plasma 0.1 mg/dL
  2019-03-29 : Globulin [Mass/volume] in Serum by calculation 2.3 g/L
  2019-03-29 : Albumin [Mass/volume] in Serum or Plasma 4.5 g/dL
  2019-03-29 : Protein [Mass/volume] in Serum or Plasma 6.3 g/dL
  2019-03-29 : Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 9.8 mL/min
  2019-03-29 : Carbon dioxide, total [Moles/volume] in Blood 27.0 mmol/L
  2019-03-29 : Chloride [Moles/volume] in Blood         108.7 mmol/L
  2019-03-29 : Potassium [Moles/volume] in Blood        4.3 mmol/L
  2019-03-29 : Sodium [Moles/volume] in Blood           137.6 mmol/L
  2019-03-29 : Calcium [Mass/volume] in Blood           8.9 mg/dL
  2019-03-29 : Creatinine [Mass/volume] in Blood        3.1 mg/dL
  2019-03-29 : Urea nitrogen [Mass/volume] in Blood     18.1 mg/dL
  2019-03-29 : Glucose [Mass/volume] in Blood           84.9 mg/dL
   
   PROCEDURES:
  2019-04-07 : Combined chemotherapy and radiation therapy (procedure) for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-04-07 : Hearing examination (procedure)
  2019-04-06 : Combined chemotherapy and radiation therapy (procedure) for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-04-06 : Hearing examination (procedure)
  2019-04-05 : Combined chemotherapy and radiation therapy (procedure) for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-04-05 : Hearing examination (procedure)
  2019-04-03 : Combined chemotherapy and radiation therapy (procedure) for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-04-03 : Hearing examination (procedure)
  2019-04-02 : Combined chemotherapy and radiation therapy (procedure) for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-04-02 : Hearing examination (procedure)
  2019-04-01 : Combined chemotherapy and radiation therapy (procedure) for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-04-01 : Hearing examination (procedure)
  2019-03-31 : Combined chemotherapy and radiation therapy (procedure) for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-03-31 : Hearing examination (procedure)
  2019-03-30 : Combined chemotherapy and radiation therapy (procedure) for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-03-30 : Hearing examination (procedure)
  2019-03-29 : Combined chemotherapy and radiation therapy (procedure) for Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2019-03-29 : Hearing examination (procedure)
   
   IMMUNIZATIONS:
   
   IMAGING STUDIES:
   
--------------------------------------------------------------------------------
CONTINUING
   
   CONDITIONS:
  2019-03-13 : Stress (finding)
  2019-03-13 : Part-time employment (finding)
  2019-02-14 : History of renal transplant (situation)
  2018-12-05 : Social isolation (finding)
  2018-10-31 : Limited social contact (finding)
  2016-05-18 : Victim of intimate partner abuse (finding)
  2016-01-11 : Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
  2016-01-08 : Small cell carcinoma of lung (disorder)
  2015-12-08 : Suspected lung cancer (situation)
  2008-12-24 : Proteinuria due to type 2 diabetes mellitus (disorder)
  2007-03-07 : Microalbuminuria due to type 2 diabetes mellitus (disorder)
  2005-05-11 : Disorder of kidney due to diabetes mellitus (disorder)
  2004-04-14 : Metabolic syndrome X (disorder)
  1997-10-29 : Body mass index 30+ - obesity (finding)
  1984-08-15 : Anemia (disorder)
  1984-08-15 : Prediabetes
  1983-08-10 : Received higher education (finding)
  1983-08-10 : Essential hypertension (disorder)
   
   MEDICATIONS:
  2019-03-20 + lisinopril 10 MG Oral Tablet for Essential hypertension (disorder)
  2019-03-20 + 24 HR tacrolimus 1 MG Extended Release Oral Tablet for History of renal transplant (situation)
  2019-03-20 + Hydrochlorothiazide 25 MG Oral Tablet for Essential hypertension (disorder)
  2019-03-20 + insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin] for Prediabetes
  1984-08-23 : Vitamin B12 5 MG/ML Injectable Solution
   
   CAREPLANS:
  2019-02-14 : Care plan (record artifact)
                         Activity: Transplantation of kidney regime (regime/therapy)
                         Activity: Post-surgical wound care (regime/therapy)
                         Activity: Renal function monitoring (regime/therapy)
                         Activity: Very low sodium diet (finding)
  2016-01-11 : Terminal care
                         Reason: Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)
                         Activity: Comfort measures
                         Activity: Chronic pain control management
                         Activity: Cancer education
  2014-12-20 : Dialysis care plan (record artifact)
                         Activity: Low salt diet education (procedure)
                         Activity: Lower limb exercises (regime/therapy)
                         Activity: Diet education (procedure)
  1984-08-15 : Diabetes self management plan
                         Reason: Prediabetes
                         Activity: Diabetic diet
                         Activity: Exercise therapy
  1983-08-10 : Lifestyle education regarding hypertension
                         Reason: Essential hypertension (disorder)
                         Activity: Prescribed activity/exercise education
                         Activity: Counseling about alcohol consumption
                         Activity: Dietary approaches to stop hypertension diet
                         Activity: Smoking cessation education
   
--------------------------------------------------------------------------------
